Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Delay in PSA and clinical progression of prostate cancer achieved using Prostvac

June 3, 2002

Final analysis of phase III data for Zamyl in AML

June 3, 2002

Second phase II trial for GVAX pancreatic cancer vaccine

May 31, 2002

Clinical data on one of Igeneon's cancer vaccine candidates discussed at ASCO meeting

May 31, 2002

Oncophage granted orphan drug status in renal cell carcinoma

May 30, 2002

IND filed for MDX-060

May 30, 2002

Intralesional CpG ODN evaluated in patients with basal cell carcinoma and melanoma

May 28, 2002

Sosei licenses KS Biomedix's TransMID product for recurrent high-grade glioma in Japan

May 28, 2002

Phase I EMD-72000 results presented at ASCO

May 28, 2002

Pharmexa prepares to file IND for AutoVac HER-2 Protein pharmaccine for breast cancer

May 27, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...